LabCorp and Mount Sinai Health System Enhance Laboratory Operations to Improve Patient Care

BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 24, 2018-- LabCorp® (NYSE: LH) and the Mount Sinai Health System today announced a significant milestone in achieving their common goal of improving laboratory services and patient care. LabCorp, a leading global life sciences company, and Mount Sinai, one

LabCorp at Walgreens Expands into Florida

Ten new patient service centers to open at Walgreens stores in April and May DEERFIELD, Ill. & BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 23, 2018-- Walgreens and LabCorp® (NYSE: LH) today announced the expansion of their LabCorp at Walgreens collaboration into Florida .

Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 2, 2018-- LabCorp® (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero Coupon Notes are convertible into cash and Common Stock of LabCorp, if any, subject

LabCorp and Appalachian Regional Healthcare Create Comprehensive Laboratory Collaboration

LabCorp’s Expertise in Health System Collaborations will Benefit Patients across Eastern Kentucky and Southern West Virginia BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 22, 2018-- LabCorp® (NYSE: LH) and Appalachian Regional Healthcare have entered into a multi-year, comprehensive laboratory

LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest

BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 12, 2018-- LabCorp® (NYSE: LH) announced today that for the period of March 12, 2018 to September 11, 2018 , its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) will accrue (subject to the terms of the Zero Coupon Notes) contingent

Covance Forms Immunology & Immunotoxicology Unit Focused on Biologic Drug Development

Global Team Addresses the Unique Scientific Needs of Safety Assessment for Biologics BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 9, 2018-- LabCorp® (NYSE: LH), a leading global life sciences company, announced today that its Covance Drug Development (Covance) business has formed a global immunology

LabCorp is Scheduled to Present at the 2018 Barclays Global Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 7, 2018-- LabCorp® (NYSE: LH) today announced it will participate at the 2018 Barclays Global Healthcare Conference . LabCorp’s presentation is planned for Wednesday, March 14, 2018 at 9:30 am (ET) . A live audio webcast of the presentation will be available

LabCorp Partners with Cheeriodicals through Community Service Campaign to Florida Hospital Memorial Medical Center and Halifax Health Medical Center

DAYTONA , Fla.--(BUSINESS WIRE)--Mar. 5, 2018-- As part of a community service campaign, an enthusiastic group of LabCorp employees teamed up with Cheeriodicals to assemble and deliver 128 big green boxes to children patients at Florida Hospital Memorial Medical Center and Halifax Health Medical

Covance Enters into Strategic Technology Agreement with GSK

Leverages Covance’s Xcellerate® Informatics Technology Across GSK’s Global Clinical Trials Portfolio BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 28, 2018-- LabCorp® (NYSE: LH), a leading global life sciences company, announced today that its Covance Drug Development (Covance) business has entered into

LabCorp is Scheduled to Present at the 39th Annual Raymond James Institutional Investors Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 23, 2018-- LabCorp® (NYSE: LH) today announced it will participate at the 39th Annual Raymond James Institutional Investors Conference . LabCorp’s presentation is scheduled for Tuesday, March 6, 2018 at 8:40 AM (ET) .